AMBELVIST 0.1 mmol/ nl sol inj ser préremp 257.9 m

7680704400028 CH-70440 V08CA13 14.02.0.

No images available

Details

Product number
7044001
CPT
-
Packaging group
10
Unit
ml
Composition
gadoquatranum 257.9 mg, corresp. 0.1 mmol corresp. gadolinium 62.9 mg, calcobutrolum, natrii chloridum, trometamolum, acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 1 ml corresp. natrium 1.235 mg.

Articles (1)

Ambelvist 0.1 mmol/ nl, Injektionslösung in einer Fertigspritze
Injektionslösung
10
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
gadoquatranum
257.9 MG Substance Wirkstoff (Principe actif)
gadolinium
62.9 MG Substance WIIS
calcobutrolum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
trometamolum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.235 MG Substance HBESI

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
70440
Drug name
Ambelvist, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
V08CA13
Authorization status
Z
Dispensation category
B
First authorization
28/08/2026
Authorization expiration date
27/08/2031
IT number
14.02.0.
Domain
Human medicine
Field of application
MRT-Kontrastmittel für die ZNS-Diagnostik und weitere Körperregionen

Packaging details

Description (FR)
AMBELVIST 0.1 mmol/ nl sol inj ser préremp 257.9 m
Description (DE)
AMBELVIST 0.1 mmol/ nl Inj Lös Fertspr 257.9 mg 10
Market launch
01/11/2026
Narcotic (BTM)
No

Other packaging sizes

AMBELVIST 0.1 mmol/ nl sol inj ser préremp 257.9 m
7.5 ML
View
Buy us a coffee Explore the data